These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15769988)

  • 1. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
    Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance.
    Charmandari E; Kino T; Ichijo T; Jubiz W; Mejia L; Zachman K; Chrousos GP
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3986-90. PubMed ID: 17635946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
    Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype.
    Charmandari E; Kino T; Souvatzoglou E; Vottero A; Bhattacharyya N; Chrousos GP
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1939-49. PubMed ID: 15070967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance.
    Charmandari E; Kino T; Ichijo T; Zachman K; Alatsatianos A; Chrousos GP
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1535-43. PubMed ID: 16449337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
    Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression.
    Charmandari E; Ichijo T; Jubiz W; Baid S; Zachman K; Chrousos GP; Kino T
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4963-8. PubMed ID: 18827003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of the hGRαT556I causing Chrousos syndrome.
    Nicolaides NC; Skyrla E; Vlachakis D; Psarra AM; Moutsatsou P; Sertedaki A; Kossida S; Charmandari E
    Eur J Clin Invest; 2016 Jan; 46(1):42-9. PubMed ID: 26541474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance.
    Ruiz M; Hedman E; Gåfvels M; Eggertsen G; Werner S; Wahrenberg H; Wikström AC
    Scand J Clin Lab Invest; 2013 Apr; 73(3):203-7. PubMed ID: 23391271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD.
    Roberts ML; Kino T; Nicolaides NC; Hurt DE; Katsantoni E; Sertedaki A; Komianou F; Kassiou K; Chrousos GP; Charmandari E
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E790-5. PubMed ID: 23426617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation of the hGR gene causing Chrousos syndrome.
    Nicolaides NC; Geer EB; Vlachakis D; Roberts ML; Psarra AM; Moutsatsou P; Sertedaki A; Kossida S; Charmandari E
    Eur J Clin Invest; 2015 Aug; 45(8):782-91. PubMed ID: 26031419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities.
    Nicolaides NC; Roberts ML; Kino T; Braatvedt G; Hurt DE; Katsantoni E; Sertedaki A; Chrousos GP; Charmandari E
    J Clin Endocrinol Metab; 2014 May; 99(5):E902-7. PubMed ID: 24483153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel causes of generalized glucocorticoid resistance.
    Charmandari E; Kino T
    Horm Metab Res; 2007 Jun; 39(6):445-50. PubMed ID: 17578762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A NOVEL GLUCOCORTICOID RECEPTOR MUTATION IN PRIMARY GENERALIZED GLUCOCORTICOID RESISTANCE DISEASE.
    Ma L; Tan X; Li J; Long Y; Xiao Z; De J; Ren Y; Tian H; Chen T
    Endocr Pract; 2020 Jun; 26(6):651-659. PubMed ID: 32045292
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells.
    Riml S; Schmidt S; Ausserlechner MJ; Geley S; Kofler R
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S65-72. PubMed ID: 15017388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human glucocorticoid receptor alpha transcript splice variants with exon 2 deletions: evidence for tissue- and cell type-specific functions.
    Geng CD; Pedersen KB; Nunez BS; Vedeckis WV
    Biochemistry; 2005 May; 44(20):7395-405. PubMed ID: 15895983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized glucocorticoid resistance accompanied with an adrenocortical adenoma and caused by a novel point mutation of human glucocorticoid receptor gene.
    Zhu HJ; Dai YF; Wang O; Li M; Lu L; Zhao WG; Xing XP; Pan H; Li NS; Gong FY
    Chin Med J (Engl); 2011 Feb; 124(4):551-5. PubMed ID: 21362280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three Novel Heterozygous Point Mutations of NR3C1 Causing Glucocorticoid Resistance.
    Vitellius G; Fagart J; Delemer B; Amazit L; Ramos N; Bouligand J; Le Billan F; Castinetti F; Guiochon-Mantel A; Trabado S; Lombès M
    Hum Mutat; 2016 Aug; 37(8):794-803. PubMed ID: 27120390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.
    Nader N; Bachrach BE; Hurt DE; Gajula S; Pittman A; Lescher R; Kino T
    J Clin Endocrinol Metab; 2010 May; 95(5):2281-5. PubMed ID: 20335448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene.
    Karl M; Lamberts SW; Detera-Wadleigh SD; Encio IJ; Stratakis CA; Hurley DM; Accili D; Chrousos GP
    J Clin Endocrinol Metab; 1993 Mar; 76(3):683-9. PubMed ID: 8445027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.